US Patent Issued to Henan Zhiwei Biomedicine on Feb. 17 for "Substituted imidazolecarboxamide as Bruton's tyrosine kinase inhibitors" (Chinese Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,798, issued on Feb. 17, was assigned to Henan Zhiwei Biomedicine Co. Ltd. (Xinxiang, China).

"Substituted imidazolecarboxamide as Bruton's tyrosine kinase inhibitors" was invented by Yuqin Jiang (Xinxiang, China), Qingjie Ding (Xinxiang, China), Chunhua Ma (Xinxiang, China), Guiqing Xu (Xinxiang, China), Dandan Zhang (Xinxiang, China), Yang Li (Xinxiang, China), Pengfei Li (Xinxiang, China), Wei Li (Xinxiang, China), Shouning Yang (Xinxiang, China), Xin Shi (Xinxiang, China) and Peipei Shi (Xinxiang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to a series of substituted imidazolecarboxamide compounds of formula I as B...